GSTM1 and Parkinson disease: Patients with dementia had lower BMI, lower rates of living at home, lower pre-injury ADLs, a larger number of comorbidities (apart from Parkinson’s disease and diabetes mellitus), a higher mFI-5, and lower Hb levels than patients without dementia; they also used a larger number of medications than patients without dementia.